Vietnam MOH registration 2402951ĐKLH/BYT-HTTB

Drug test, quantitative test standard NT-proBNP

VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định lượng NT-proBNP

Vietnam·Risk Class TTBYT Loại C·Theo theo phụ lục·Siemens Healthcare Diagnostics Inc·Registered Oct 22, 2024

Registration details

Analysis ID: 2402951ĐKLH/BYT-HTTB
Submission ID: 000.00.04.G18-231115-0014
Product Type: Theo theo phụ lục
Product Code: Theo phụ lục

Company information

Manufacturer: Siemens Healthcare Diagnostics Inc
Manufacturer Country: Theo theo phụ lục
Product Owner: Siemens Healthcare Diagnostics Inc
Authorized Representative: CÔNG TY TNHH SIEMENS HEALTHCARE

Technical details

Intended Use: The ADVIA Centaur NT-proBNP (PBNP) test is an in vitro diagnostic test used to quantify the concentration of N-terminal pro-brain natriuretic peptide (NT-proBNP) in human serum and plasma on the ADVIA Centaur CP, ADVIA Centaur XP, and ADVIA Centaur XPT systems. In patients suspected of having congestive heart failure (CHF), measurements of NT-proBNP are used to aid in diagnosis and to assess the severity of the condition.

Dates and status

Registration Date: Oct 22, 2024

About this record

Access comprehensive regulatory information for Drug test, quantitative test standard NT-proBNP in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402951ĐKLH/BYT-HTTB and manufactured by Siemens Healthcare Diagnostics Inc. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.